X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs IPCA LABS - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE IPCA LABS CADILA HEALTHCARE/
IPCA LABS
 
P/E (TTM) x 13.5 25.3 53.5% View Chart
P/BV x 2.8 4.3 66.3% View Chart
Dividend Yield % 1.4 0.1 1,316.3%  

Financials

 CADILA HEALTHCARE   IPCA LABS
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
IPCA LABS
Mar-18
CADILA HEALTHCARE/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs558695 80.2%   
Low Rs362400 90.4%   
Sales per share (Unadj.) Rs116.3260.2 44.7%  
Earnings per share (Unadj.) Rs17.919.0 94.2%  
Cash flow per share (Unadj.) Rs23.133.1 70.0%  
Dividends per share (Unadj.) Rs3.501.00 350.0%  
Dividend yield (eoy) %0.80.2 417.0%  
Book value per share (Unadj.) Rs85.4213.0 40.1%  
Shares outstanding (eoy) m1,023.74126.20 811.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.1 187.8%   
Avg P/E ratio x25.728.9 89.1%  
P/CF ratio (eoy) x19.916.6 120.0%  
Price / Book Value ratio x5.42.6 209.4%  
Dividend payout %19.65.3 371.6%   
Avg Mkt Cap Rs m470,66469,120 680.9%   
No. of employees `00011.813.3 89.2%   
Total wages/salary Rs m18,5457,359 252.0%   
Avg. sales/employee Rs Th10,072.72,477.4 406.6%   
Avg. wages/employee Rs Th1,569.1555.2 282.6%   
Avg. net profit/employee Rs Th1,547.7180.6 856.8%   
INCOME DATA
Net Sales Rs m119,04932,836 362.6%  
Other income Rs m1,132418 270.8%   
Total revenues Rs m120,18133,254 361.4%   
Gross profit Rs m28,4754,505 632.1%  
Depreciation Rs m5,3881,777 303.2%   
Interest Rs m911240 379.3%   
Profit before tax Rs m23,3082,905 802.3%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644511 1,104.3%   
Profit after tax Rs m18,2922,394 764.0%  
Gross profit margin %23.913.7 174.3%  
Effective tax rate %24.217.6 137.6%   
Net profit margin %15.47.3 210.7%  
BALANCE SHEET DATA
Current assets Rs m82,00519,455 421.5%   
Current liabilities Rs m60,72010,076 602.6%   
Net working cap to sales %17.928.6 62.6%  
Current ratio x1.41.9 69.9%  
Inventory Days Days7398 74.7%  
Debtors Days Days9867 146.8%  
Net fixed assets Rs m83,70320,260 413.2%   
Share capital Rs m1,024252 405.7%   
"Free" reserves Rs m86,42126,633 324.5%   
Net worth Rs m87,44526,886 325.2%   
Long term debt Rs m25,5512,340 1,091.9%   
Total assets Rs m180,65341,173 438.8%  
Interest coverage x26.613.1 203.0%   
Debt to equity ratio x0.30.1 335.7%  
Sales to assets ratio x0.70.8 82.6%   
Return on assets %10.66.4 166.1%  
Return on equity %20.98.9 234.9%  
Return on capital %22.010.8 204.3%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m42,68315,642 272.9%   
Fx outflow Rs m11,2424,884 230.2%   
Net fx Rs m31,44110,759 292.2%   
CASH FLOW
From Operations Rs m9,1933,411 269.5%  
From Investments Rs m-9,737-1,354 719.1%  
From Financial Activity Rs m515-1,304 -39.5%  
Net Cashflow Rs m-29753 -3.9%  

Share Holding

Indian Promoters % 74.8 45.9 163.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 11.4 72.8%  
FIIs % 5.9 25.3 23.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.4 63.2%  
Shareholders   44,069 36,892 119.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips 300 Points; Tata Steel & Vedanta Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. Barring IT sector, all sectoral indices are trading in red with stocks in the metal sector.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

FM Nirmala Sitharaman Inherits an Economy Facing a Number of Headwinds(Sector Info)

Jun 4, 2019

The Indian economy is in a major slowdown. Will the new finance minister, Nirmala Sitharaman bring the much-needed reforms?

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 17, 2019 03:33 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS